In a current article revealed in Nanomaterials, researchers investigated the potential of chitosan nanoparticles (CHNPs) as a supply system for curcumin, aiming to enhance its therapeutic efficacy in opposition to breast most cancers.
Picture Credit score: CI Photographs/Shutterstock.com
Background
Chitosan, a biopolymer obtained from chitin, is understood for its biocompatibility, biodegradability, and skill to encapsulate varied therapeutic brokers. The ionic gelation technique is a broadly used approach for synthesizing chitosan nanoparticles, permitting for the formation of secure nanosuspensions. The incorporation of curcumin into chitosan nanoparticles is predicted to reinforce its solubility and bioavailability, thereby bettering its anti-cancer results.
Whereas curcumin has been proven to induce apoptosis in most cancers cells and inhibit tumor development, its poor pharmacokinetic properties restrict its medical software.
The Present Examine
To synthesize the CHNPs, tripolyphosphate (TPP) was used as a cross-linking agent, facilitating the ionic gelation of chitosan and leading to nanoparticle formation. These CHNPs had been then characterised utilizing dynamic mild scattering (DLS) to measure particle dimension and zeta potential. A zeta potential measurement was carried out to evaluate nanoparticle stability in suspension, with values above +30 mV indicating good stability on account of electrostatic repulsion.
To load curcumin into the chitosan nanoparticles, a particular weight ratio of curcumin to chitosan was established, and curcumin was encapsulated inside the nanoparticles. The combination was centrifuged to separate unencapsulated curcumin from the nanoparticle suspension. The supernatant was collected, and the quantity of curcumin within the supernatant was quantified utilizing UV-visible spectrophotometry to calculate encapsulation effectivity.
In vitro research had been performed utilizing breast most cancers cell traces, which had been cultured in a development medium supplemented with fetal bovine serum (FBS) and antibiotics. The cytotoxicity of the curcumin-loaded CHNPs was assessed utilizing the MTT assay, the place cells had been seeded in 96-well plates and handled with various concentrations of free curcumin and Cur-CHNPs. Absorbance was measured at 570 nm utilizing a microplate reader, and the proportion of cell viability was calculated.
For in vivo research, male BALB/c mice had been acclimatized for one week earlier than the experiment. Breast most cancers was induced by subcutaneously injecting the mice with a particular variety of most cancers cells. As soon as the tumors reached a predetermined dimension, the mice had been randomly assigned to completely different therapy teams, together with these receiving free curcumin and people receiving Cur-CHNPs. The therapies had been administered orally, with dosages calculated based mostly on the mice’s physique weight.
Tumor development was monitored by measuring the scale of the tumors. Hematological and biochemical parameters had been evaluated to evaluate the protection and toxicity of the therapies. Blood samples had been collected, and varied assays had been performed to research liver and kidney operate, in addition to full blood counts.
Outcomes and Dialogue
Physicochemical characterization revealed that the optimized chitosan nanoparticles had been roughly 85 nm in dimension, whereas the curcumin-loaded nanoparticles measured round 118 nm. The optimistic zeta potential, which is favorable for mobile uptake, indicated that the nanoparticles had been well-suited for therapeutic use.
The research demonstrated that Cur-CHNPs had enhanced solubility in aqueous options in comparison with free curcumin, suggesting improved bioavailability. Lengthy-term stability assessments confirmed that the nanoparticles maintained their dimension with out aggregation over 74 days, highlighting their potential for sustained launch functions.
In vitro research indicated that Cur-CHNPs considerably inhibited the proliferation of breast most cancers cells extra successfully than free curcumin. This impact was attributed to the induction of apoptosis and cell cycle arrest, which had been confirmed by way of varied assays.
In vivo experiments supported these findings, exhibiting a marked discount in tumor quantity in mice handled with Cur-CHNPs in comparison with management teams. The research additionally assessed the acute and subchronic toxicity of Cur-CHNPs, revealing no important opposed results on the hematological and biochemical parameters of the handled mice. These outcomes underscore the protection and efficacy of chitosan nanoparticles as a supply system for curcumin in breast most cancers remedy.
The flexibility of Cur-CHNPs to reinforce curcumin’s solubility and bioavailability presents a promising method to overcoming the constraints related to conventional curcumin administration. The research additionally highlighted the potential of chitosan nanoparticles as a flexible platform for delivering different therapeutic brokers, paving the best way for future analysis on this space.
Conclusion
In conclusion, the in vitro and in vivo outcomes point out that Cur-CHNPs not solely suppress tumor development but in addition exhibit a positive security profile, making them a promising candidate for additional growth in most cancers remedy.
This analysis helps the usage of nanotechnology in bettering drug supply methods, notably for compounds with restricted medical applicability. Future research are required to discover the long-term results and potential medical functions of Cur-CHNPs for varied most cancers sorts.
Journal Reference
Mishra B., et al. (2024). Chitosan Nanoparticle-Mediated Supply of Curcumin Suppresses Tumor Development in Breast Most cancers. Nanomaterials. DOI: 10.3390/nano14151294, https://www.mdpi.com/2079-4991/14/15/1294